Sol-Gel Technologies, Ltd.
Clinical trials sponsored by Sol-Gel Technologies, Ltd., explained in plain language.
Develops topical dermatological drugs using silica-based delivery technology.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New gel could slash facial skin cancers in rare genetic condition Results expected Oct 2026 (estimated) 🚀 Make-or-break